Low dose rivaroxaban for secondary prophylaxis after full anticoagulation in patients with venous thromboembolism

被引：0
|
作者：
Zhou, A. [1 ]
Chan, A. K. [2 ]
Lau, K. K. [3 ]
Chan, H. H. [4 ]
机构：
[1] McMaster Univ, Honours Integrated Sci Program, Hamilton, ON, Canada
[2] McMaster Univ, Pediat, Hamilton, ON, Canada
[3] Univ Hong Kong, Shenzhen Hosp, Pediat, Shenzhen, Peoples R China
[4] McMaster Univ, Med, Hamilton, ON, Canada
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO359-TUE
引用
收藏
页码：637 / 638
页数：2
相关论文
共 50 条
  • [41] Evaluation of VTE-PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis
    Lagana, Alessandro
    Assanto, Giovanni Manfredi
    Passucci, Mauro
    Santoro, Cristina
    Chistolini, Antonio
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [42] Rivaroxaban for the treatment of venous thromboembolism in pediatric patients
    Cohen, Omri
    Levy-Mendelovich, Sarina
    Ageno, Walter
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (11) : 733 - 741
  • [43] No Difference Between Low-and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA
    Faour, Mhamad
    Piuzzi, Nicolas S.
    Brigati, David P.
    Klika, Alison K.
    Mont, Michael A.
    Barsoum, Wael K.
    Higuera, Carlos A.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2019, 477 (02) : 396 - 402
  • [44] PILOT STUDY OF APIXABAN IN SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN PEDIATRIC PATIENTS
    Pinchinat, Ashley
    Levendoglu-Tugal, Oya
    Perez, Yara
    Otero, Neida
    Budhram, Arvind
    Mahanti, Harshini
    Morris, Erin
    Brudnicki, Adele
    Friedman, Deborah
    Li, Simon
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S94 - S94
  • [45] A PILOT STUDY OF APIXABAN AS SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN PEDIATRIC PATIENTS
    Pinchinat, Ashley
    Levendoglu-Tugal, Oya
    Perez, Yara
    Thatcher, Emily
    Otero, Neida
    Budhram, Arvind
    Mahanti, Harshini
    Morris, Erin
    Schaefer, Edo
    Brudnicki, Adele
    Friedman, Deborah
    Li, Simon
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [46] Venous thromboembolism prophylaxis with rivaroxaban subsequent to enoxaparin in major orthopaedic surgery
    Altintas, F.
    Ulucay, C.
    Ozler, T.
    Kilincoglu, V
    Guzelbey, T.
    Aksu, B. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1115 - 1115
  • [47] DOSE-ADJUSTED ENOXAPARIN FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN TRAUMA PATIENTS
    Phillips, Janise
    Ezekiel, Tanya
    Mohorn, Phillip
    Watson, Christopher
    Reeves, Jeremy
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [48] High-Dose Venous Thromboembolism Prophylaxis for Obese Patients Reply
    Samuel, Sophie
    Choi, H. Alex
    PHARMACOTHERAPY, 2016, 36 (11): : E199 - E199
  • [49] Rivaroxaban versus low weight heparins for venous thromboembolism prophylaxis after major hip and knee arthroplasty: systematic review and metaanalysis
    Aristizabal Henao, Natalia
    Montoya Lopera, Juan Pablo
    Donado Gomez, Jorge Hernando
    IATREIA, 2013, 26 (02) : 136 - 152
  • [50] Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative
    Barkoudah, Ebrahim
    Piazza, Gregory
    Hecht, Todd E. H.
    Grant, Paul
    Deitelzweig, Steven
    Fang, Margaret C.
    Fanikos, John
    Kao, Cheng-Kai
    Barnes, Geoffrey D.
    Chen, Thomas
    Ramishvili, Tea
    Schnipper, Jeffrey L.
    Goldstein, Jennifer N.
    Ruff, Christian T.
    Kaatz, Scott
    Schwartz, Aviva
    Connors, Jean M.
    Goldhaber, Samuel Z.
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 : 1 - 27
12345